Institut Mérieux has returned for a $26.5m round for surgical technology developer Keranova, having previously supported a $4.6m round three and a half years ago.

Keranova, a France-based cataract treatment spinout of Jean Monnet University, has raised €24m ($26.5m) in funding from investors including Mérieux Equity Partners, an investment vehicle for medical holding group Institut Mérieux, according to La Tribune.
Supernova Invest, Financière Arbevel, Tourrette Investissement and several undisclosed international investors also took part in the round.
Founded in 2016, Keranova is working on non-invasive surgical technology that will combine robotics and a high-speed laser with imaging technology to assist the surgeon who…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in